5. In which populations can the PG-SGA© be used?

In the original study of the scoring in 1996, patient population was not limited to oncology patients, although they were the predominant group (Lung, Prostate, Colon, NHL, Rectal, Esophageal, Melanoma, Cervical), but included patients with End stage...
Read More

2. Can I use the PG-SGA© in research?

Yes. The PG-SGA© provides a consistent means of identifying patients with malnutrition and measuring outcomes of nutrition intervention. The PG-SGA© has been used extensively in multiple different patient populations and settings. During the past two...
Read More